Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO)
CUSIP: 68621F102
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 127,085,490
- Total 13F shares
- 1,463,592
- Share change
- +651,058
- Total reported value
- $11,124,205
- Price per share
- $7.60
- Number of holders
- 27
- Value change
- +$4,972,528
- Number of buys
- 20
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 68621F102?
CUSIP 68621F102 identifies ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68621F102:
Top shareholders of ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.19%
|
242,440
|
$1,818,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
133,811
|
$1,003,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
101,512
|
$761,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
67,968
|
$510,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
63,315
|
$475,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
59,215
|
$444,000 | — | 31 Mar 2019 | |
| Tibra Equities Europe Ltd |
13F
|
Company |
0.04%
|
46,366
|
$348,000 | — | 31 Mar 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
26,936
|
$202,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
17,526
|
$131,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
14,991
|
$112,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
11,690
|
$88,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
10,829
|
$81,000 | — | 31 Mar 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
4,437
|
$74,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
5,570
|
$42,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
5,479
|
$41,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4,059
|
$30,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
800
|
$6,000 | — | 31 Mar 2019 | |
| GLAZER CAPITAL, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q2 2019
As of 30 Jun 2019,
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,463,592 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Moors & Cabot, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Bank of New York Mellon Corp, NUVEEN ASSET MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Assenagon Asset Management S.A..
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
16
Q2 2019 holders
27
Holder diff
11
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.